1 - 25 of 165
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Biontech Se USD Put 100,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 6,21x
- Analysis
- Biontech Se USD Put 90,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 8,26x
- Analysis
- Biontech Se USD Call 150,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 6,74x
- Analysis
- Biontech Se USD Call 100,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 8,79x
- Analysis
- Biontech Se USD Call 90,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 6,76x
- Analysis
- Biontech Se USD Call 120,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 9,32x
- Analysis
- Biontech Se USD Put 50,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 3,70x
- Analysis
- Biontech Se USD Put 60,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 4,61x
- Analysis
- Biontech Se USD Put 80,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 8,09x
- Analysis
- Biontech Se USD Call 140,00 20 Feb 2026
- Goldman Sachs
- 20.02.26
- 8,14x
- Analysis
- Biontech Se USD Put 80,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 2,88x
- Analysis
- Biontech Se USD Call 90,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,68x
- Analysis
- Biontech Se USD Call 90,00 18 Jun 2026
- Goldman Sachs
- 18.06.26
- 4,10x
- Analysis
- Biontech Se USD Put 65,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 5,32x
- Analysis
- Biontech Se USD Put 85,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 11,80x
- Analysis
- Biontech Se USD Put 95,00 16 Jan 2026
- Goldman Sachs
- 16.01.26
- 11,24x
- Analysis
- Biontech Se USD Call 110,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,20x
- Analysis
- Biontech Se USD Call 105,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,16x
- Analysis
- Biontech Se USD Call 103,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,14x
- Analysis
- Biontech Se USD Call 91,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,05x
- Analysis
- Biontech Se USD Call 90,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,03x
- Analysis
- Biontech Se USD Call 109,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,21x
- Analysis
- Biontech Se USD Call 106,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,19x
- Analysis
- Biontech Se USD Call 98,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,10x
- Analysis
- Biontech Se USD Call 108,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,22x
- Analysis